{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:52:38Z","timestamp":1788447158534,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12010-023-04808-z","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T08:02:12Z","timestamp":1705737732000},"page":"6222-6233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma MCP-1 and TGF-\u03b21 Levels are Associated with Kidney Injury in Children with Congenital Anomalies of the Kidney and Urinary Tract"],"prefix":"10.1007","volume":"196","author":[{"given":"XiaoQi","family":"Xuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinLong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongLe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4674-8612","authenticated-orcid":false,"given":"JianGuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"issue":"12","key":"4808_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrneph.2015.140","volume":"11","author":"N Nicolaou","year":"2015","unstructured":"Nicolaou, N., et al. (2015). Genetic, environmental, and epigenetic factors involved in CAKUT. Nature Reviews Nephrology, 11(12), 720\u2013731.","journal-title":"Nature Reviews Nephrology"},{"issue":"4","key":"4808_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00467-013-2684-4","volume":"29","author":"A Vivante","year":"2014","unstructured":"Vivante, A., et al. (2014). Single-gene causes of congenital anomalies of the kidney and urinary tract (CAKUT) in humans. Pediatric Nephrology(Berlin, Germany), 29(4), 695\u2013704.","journal-title":"Pediatric Nephrology(Berlin, Germany)"},{"issue":"1","key":"4808_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2215\/CJN.03310412","volume":"8","author":"E Wuhl","year":"2013","unstructured":"Wuhl, E., et al. (2013). Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clinical Journal of the American Society of Nephrology, 8(1), 67\u201374.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"10","key":"4808_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00439-019-02042-4","volume":"138","author":"TM Kitzler","year":"2019","unstructured":"Kitzler, T. M., et al. (2019). COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans. Human Genetics, 138(10), 1105\u20131115.","journal-title":"Human Genetics"},{"issue":"5","key":"4808_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2215\/CJN.12581019","volume":"15","author":"V Murugapoopathy","year":"2020","unstructured":"Murugapoopathy, V., & Gupta, I. R. (2020). A primer on congenital anomalies of the kidneys and urinary tracts (CAKUT). Clinical Journal of the American Society of Nephrology, 15(5), 723\u2013731.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"4","key":"4808_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00467-013-2606-5","volume":"29","author":"TK Davis","year":"2014","unstructured":"Davis, T. K., Hoshi, M., & Jain, S. (2014). To bud or not to bud: The RET perspective in CAKUT. Pediatric Nephrology(Berlin, Germany), 29(4), 597\u2013608.","journal-title":"Pediatric Nephrology(Berlin, Germany)"},{"key":"4808_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fped.2019.00222","volume":"7","author":"MM Gabriele","year":"2019","unstructured":"Gabriele, M. M., & Koch Nogueira, P. C. (2019). Management of Hypertension in CAKUT: Protective factor for CKD. Front Pediatr, 7, 222.","journal-title":"Front Pediatr"},{"issue":"2","key":"4808_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1681\/ASN.2010040356","volume":"22","author":"D Laouari","year":"2011","unstructured":"Laouari, D., et al. (2011). TGF-alpha mediates genetic susceptibility to chronic Kidney Disease. Journal of the American Society of Nephrology, 22(2), 327\u2013335.","journal-title":"Journal of the American Society of Nephrology"},{"key":"4808_CR9","doi-asserted-by":"crossref","unstructured":"Wang, L., et al. (2021). TGF-Beta as a Master Regulator of Diabetic Nephropathy. International Journal of Molecular Sciences, 22(15).","DOI":"10.3390\/ijms22157881"},{"issue":"6","key":"4808_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2009060592","volume":"21","author":"Q Cao","year":"2010","unstructured":"Cao, Q., et al. (2010). IL-10\/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin Nephrosis. Journal of the American Society of Nephrology, 21(6), 933\u2013942.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"4808_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/labinvest.2009.149","volume":"90","author":"D Zhang","year":"2010","unstructured":"Zhang, D., et al. (2010). Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta\/Smad activity. Laboratory Investigation, 90(3), 436\u2013447.","journal-title":"Laboratory Investigation"},{"issue":"3","key":"4808_CR12","doi-asserted-by":"publisher","first-page":"F703","DOI":"10.1152\/ajprenal.00254.2005","volume":"290","author":"W Qi","year":"2006","unstructured":"Qi, W., et al. (2006). TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol, 290(3), F703\u2013F709.","journal-title":"Am J Physiol Renal Physiol"},{"key":"4808_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3389\/fphar.2018.00900","volume":"9","author":"Z Yang","year":"2018","unstructured":"Yang, Z., et al. (2018). miR-374a regulates inflammatory response in Diabetic Nephropathy by Targeting MCP-1 expression. Frontiers in Pharmacology, 9, 900.","journal-title":"Frontiers in Pharmacology"},{"key":"4808_CR14","doi-asserted-by":"publisher","first-page":"118808","DOI":"10.1016\/j.lfs.2020.118808","volume":"272","author":"Q Du","year":"2021","unstructured":"Du, Q., et al. (2021). Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1\/CCR2 axis in diabetic Nephropathy. Life Sciences, 272, 118808.","journal-title":"Life Sciences"},{"issue":"8","key":"4808_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/exd.13260","volume":"26","author":"LR Luckett-Chastain","year":"2017","unstructured":"Luckett-Chastain, L. R., et al. (2017). Interleukin (IL)-6 modulates transforming growth factor-beta receptor I and II (TGF-betaRI and II) function in epidermal keratinocytes. Experimental Dermatology, 26(8), 697\u2013704.","journal-title":"Experimental Dermatology"},{"issue":"9","key":"4808_CR16","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1172\/JCI85939","volume":"126","author":"CE Pedigo","year":"2016","unstructured":"Pedigo, C. E., et al. (2016). Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. J Clin Invest, 126(9), 3336\u20133350.","journal-title":"J Clin Invest"},{"issue":"4","key":"4808_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ki.2014.330","volume":"87","author":"ME Pavkov","year":"2015","unstructured":"Pavkov, M. E., et al. (2015). Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal Disease in American indians with type 2 Diabetes. Kidney International, 87(4), 812\u2013819.","journal-title":"Kidney International"},{"issue":"5","key":"4808_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.ajkd.2013.06.008","volume":"62","author":"AS Kliger","year":"2013","unstructured":"Kliger, A. S., et al. (2013). KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. American Journal of Kidney Diseases, 62(5), 849\u2013859.","journal-title":"American Journal of Kidney Diseases"},{"key":"4808_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","volume":"98","author":"IH de Boer","year":"2020","unstructured":"de Boer, I. H., et al. (2020). Kidney Disease: Improving global outcomes (KDIGO) Diabetes Work Group,KDIGO 2020 Clinical Practice Guideline for Diabetes Management in chronic Kidney Disease. [J] Kidney Int, 98, S1\u2013S115.","journal-title":"[J] Kidney Int"},{"key":"4808_CR20","doi-asserted-by":"crossref","unstructured":"Chapter 1: Definition and classification of CKD.[J].Kidney Int Suppl (2011) (2013). 3: 19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"issue":"3","key":"4808_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J., et al. (2009). New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, 20(3), 629\u2013637.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"4808_CR22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/jcm8081090","volume":"8","author":"CN Hsu","year":"2019","unstructured":"Hsu, C. N., Lu, P. C., et al. (2019). Blood pressure abnormalities Associated with Gut Microbiota-Derived short chain fatty acids in children with congenital anomalies of the kidney and urinary tract. Journal of Clinical Medicine, 8(8), 1090.","journal-title":"Journal of Clinical Medicine"},{"key":"4808_CR23","first-page":"502","volume":"45","author":"G Lippi","year":"2012","unstructured":"Lippi, G., Dipalo, M. (2012). Evaluation of the Analytical Performances of the Novel Beckman Coulter AU5800 [J] Clin Biochem, 45: 502\u2013504.","journal-title":"Evaluation of the Analytical Performances of the Novel Beckman Coulter AU5800 [J] Clin Biochem"},{"key":"4808_CR24","first-page":"153","volume":"58","author":"Q Zhou","year":"2012","unstructured":"Zhou, Q., Xie, W., et al. (2012). Calibration verification for Olympus and Hitachi automatic biochemistry analyzers using albumin. [J] Clin Lab, 58, 153\u2013159.","journal-title":"[J] Clin Lab"},{"issue":"6","key":"4808_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2215\/CJN.11971116","volume":"12","author":"DY Fuhrman","year":"2017","unstructured":"Fuhrman, D. Y., et al. (2017). Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD. Clinical Journal of the American Society of Nephrology, 12(6), 912\u2013920.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"4808_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fphar.2019.01192","volume":"10","author":"V Andrade-Oliveira","year":"2019","unstructured":"Andrade-Oliveira, V., et al. (2019). Inflammation in renal Diseases: New and Old players. Frontiers in Pharmacology, 10, 1192.","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"4808_CR27","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur, R. L., et al. (2016). Inflammation and progression of CKD: The CRIC Study. Clinical Journal of the American Society of Nephrology, 11(9), 1546\u20131556.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"4808_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.phrs.2014.02.007","volume":"81","author":"D Impellizzeri","year":"2014","unstructured":"Impellizzeri, D., et al. (2014). Targeting inflammation: New therapeutic approaches in chronic Kidney Disease (CKD). Pharmacological Research, 81, 91\u2013102.","journal-title":"Pharmacological Research"},{"key":"4808_CR29","doi-asserted-by":"crossref","unstructured":"Mihai, S. (2019). Inflammation-Related Patterns in the Clinical Staging and Severity Assessment of Chronic Kidney Disease Dis Markers, 2019: p.\u00a01814304.","DOI":"10.1155\/2019\/1814304"},{"issue":"3","key":"4808_CR30","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfq471","volume":"26","author":"A Upadhyay","year":"2011","unstructured":"Upadhyay, A., et al. (2011). Inflammation, kidney function and albuminuria in the Framingham offspring cohort. Nephrology, Dialysis, Transplantation, 26(3), 920\u2013926.","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"3","key":"4808_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2215\/CJN.05540512","volume":"8","author":"VO Shah","year":"2013","unstructured":"Shah, V. O., et al. (2013). Plasma metabolomic profiles in different stages of CKD. Clinical Journal of the American Society of Nephrology, 8(3), 363\u2013370.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"8","key":"4808_CR32","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s11255-019-02201-6","volume":"51","author":"K Siddiqui","year":"2019","unstructured":"Siddiqui, K., Joy, S. S., & Al-Rubeaan, K. (2019). Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic Kidney Disease in type 2 Diabetes patients. International Urology and Nephrology, 51(8), 1379\u20131386.","journal-title":"International Urology and Nephrology"},{"issue":"6","key":"4808_CR33","doi-asserted-by":"publisher","first-page":"e99633","DOI":"10.1371\/journal.pone.0099633","volume":"9","author":"B Yi","year":"2014","unstructured":"Yi, B., et al. (2014). Nuclear NF-kappaB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic Nephropathy. PLoS One, 9(6), e99633.","journal-title":"PLoS One"},{"issue":"6","key":"4808_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jdiacomp.2012.06.006","volume":"26","author":"SM Titan","year":"2012","unstructured":"Titan, S. M., et al. (2012). Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic Nephropathy. J Diabetes Complications, 26(6), 546\u2013553.","journal-title":"J Diabetes Complications"},{"issue":"1\u20133","key":"4808_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.regpep.2011.09.005","volume":"173","author":"P Rutkowski","year":"2012","unstructured":"Rutkowski, P., et al. (2012). Decrease of serum chemerin concentration in patients with end stage renal Disease after successful kidney transplantation. Regulatory Peptides, 173(1\u20133), 55\u201359.","journal-title":"Regulatory Peptides"},{"issue":"2","key":"4808_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/CS20201213","volume":"135","author":"CC Gifford","year":"2021","unstructured":"Gifford, C. C., et al. (2021). Negative regulators of TGF-beta1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities. Clin Sci (Lond), 135(2), 275\u2013303.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"4808_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5582\/bst.2015.01129","volume":"9","author":"F Qi","year":"2015","unstructured":"Qi, F., et al. (2015). Adenovirus-mediated P311 inhibits TGF-beta1-induced epithelial-mesenchymal transition in NRK-52E cells via TGF-beta1-Smad-ILK pathway. Bioscience Trends, 9(5), 299\u2013306.","journal-title":"Bioscience Trends"},{"key":"4808_CR38","doi-asserted-by":"crossref","unstructured":"Gao, R. (2023). The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGFbeta-Induced Endothelial-to-Mesenchymal Transition Oxid Med Cell Longev, 2023: p.\u00a05012474.","DOI":"10.1155\/2023\/5012474"},{"issue":"3","key":"4808_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semnephrol.2012.04.002","volume":"32","author":"HY Lan","year":"2012","unstructured":"Lan, H. Y., & Chung, A. C. (2012). TGF-beta\/Smad signaling in Kidney Disease. Seminars in Nephrology, 32(3), 236\u2013243.","journal-title":"Seminars in Nephrology"},{"key":"4808_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fphys.2015.00082","volume":"6","author":"XM Meng","year":"2015","unstructured":"Meng, X. M., et al. (2015). TGF-beta\/Smad signaling in renal fibrosis. Frontiers in Physiology, 6, 82.","journal-title":"Frontiers in Physiology"},{"issue":"8","key":"4808_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1159\/000517619","volume":"52","author":"A Chalkia","year":"2021","unstructured":"Chalkia, A., et al. (2021). Transforming growth Factor-beta1\/Smad Signaling in Glomerulonephritis and its association with progression to chronic Kidney Disease. American Journal of Nephrology, 52(8), 653\u2013665.","journal-title":"American Journal of Nephrology"},{"issue":"1","key":"4808_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cyto.2014.10.009","volume":"72","author":"R Vasanthakumar","year":"2015","unstructured":"Vasanthakumar, R., et al. (2015). Serum IL-9, IL-17, and TGF-beta levels in subjects with diabetic Kidney Disease (CURES-134). Cytokine, 72(1), 109\u2013112.","journal-title":"Cytokine"},{"key":"4808_CR43","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.2147\/DDDT.S274191","volume":"14","author":"C Guo","year":"2020","unstructured":"Guo, C., et al. (2020). Chrysophanol inhibits the Progression of Diabetic Nephropathy via inactivation of TGF-beta pathway. Drug Design, Development and Therapy, 14, 4951\u20134962.","journal-title":"Drug Design, Development and Therapy"},{"issue":"2","key":"4808_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1875-5364(18)30034-7","volume":"16","author":"HB Weng","year":"2018","unstructured":"Weng, H. B., et al. (2018). Taxus Chinensis ameliorates diabetic Nephropathy through down-regulating TGF-beta1\/Smad pathway. Chinese Journal of Natural Medicines, 16(2), 90\u201396.","journal-title":"Chinese Journal of Natural Medicines"},{"key":"4808_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.omtn.2022.04.002","volume":"28","author":"J Li","year":"2022","unstructured":"Li, J., et al. (2022). MicroRNA-10a\/b inhibit TGF-beta\/Smad-induced renal fibrosis by targeting TGF-beta receptor 1 in diabetic Kidney Disease. Mol Ther Nucleic Acids, 28, 488\u2013499.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"4808_CR46","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/j.1349-7006.2010.01609.x","volume":"101","author":"H Mutoh","year":"2010","unstructured":"Mutoh, H., et al. (2010). Monocyte chemoattractant protein-1 is generated via TGF-beta by myofibroblasts in gastric intestinal metaplasia and carcinoma without H. pylori Infection. Cancer Science, 101(8), 1783\u20131789.","journal-title":"Cancer Science"},{"issue":"5","key":"4808_CR47","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1681\/ASN.2010080890","volume":"22","author":"Y Dai","year":"2011","unstructured":"Dai, Y., et al. (2011). A2B adenosine receptor-mediated induction of IL-6 promotes CKD. Journal of the American Society of Nephrology, 22(5), 890\u2013901.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5\u20136","key":"4808_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00011-022-01574-2","volume":"71","author":"I Lousa","year":"2022","unstructured":"Lousa, I., et al. (2022). Inflammatory biomarkers in staging of chronic Kidney Disease: Elevated TNFR2 levels accompanies renal function decline. Inflammation Research, 71(5\u20136), 591\u2013602.","journal-title":"Inflammation Research"},{"issue":"6","key":"4808_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/nep.12398","volume":"20","author":"K Singh","year":"2015","unstructured":"Singh, K., et al. (2015). Association of tumour necrosis factor-alpha polymorphism in patients with end stage renal Disease. Nephrology (Carlton), 20(6), 387\u2013391.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"4808_CR50","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5301\/jn.5000152","volume":"26","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit, I., et al. (2013). Role of neutrophil\/lymphocyte ratio in prediction of Disease progression in patients with stage-4 chronic Kidney Disease. Journal of Nephrology, 26(2), 358\u2013365.","journal-title":"Journal of Nephrology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04808-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04808-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04808-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:17:56Z","timestamp":1732807076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04808-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4808"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04808-z","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"9 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of WuXi Children\u2019s Hospital and written informed consent was provided by all patients prior to the study start. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}